Skip to main content

Advertisement

SpringerLink
Log in

Safety and efficacy of 1020 consecutive laparoscopic sleeve gastrectomies performed as a primary treatment modality for morbid obesity. A single-center experience from the metabolic and bariatric surgical accreditation quality and improvement program

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

LSG is widely accepted as a definitive treatment for obesity. Due to lack of large series with long-term follow-up, disagreement remains regarding its safety and efficacy. We present a series of 1020 consecutive LSGs performed with long-term follow-up.

Methods

A retrospective review of a prospectively collected database was conducted on patients who underwent LSG from January 2005 to February 2014. Data included weight, height, BMI, ideal body weight, comorbid conditions, intraoperative complications, mean length of hospital stay (LOS), early (<30 days) readmission, early and late (>30 days) postoperative complications, and percentage of excess weight loss (%EWL).

Results

Of the 1020 patients, 66.6 % (n = 679) were female, with a mean age of 38.4 ± 16.5 years. Mean BMI at the time of first visit was 43.4 ± 5.8 kg/m2. The most common comorbid conditions identified were diabetes mellitus (89.4 %), sleep apnea (86.4 %), hypertension (80.3 %), and hyperlipidemia (70 %). Over the entire follow-up period, 57 % of diabetic patients experienced significant improvement or remission. There was no mortality in this series. Early postoperative complications within 30 days of surgery included leak in 0.1 % (n = 1), stricture in 0.1 % (n = 1), emesis in 23 % (n = 234), dehydration in 19 % (n = 194), prolonged ileus in 18 % (183), and self-limited bleeding in 3 % (n = 30). Mean LOS was of 3.4 ± 2.1 days, with a 3.8 % overall rate of early readmissions. Long-term morbidity was found in 3.9 % of patients (n = 40) and included stricture in 0.49 % (n = 5) and GERD in 6 % (n = 61). The overall 30-day mortality rate was 0 %. Mean %EWL at 3 months to 1, 3, 5, and 8 years was 72 ± 16.8, 86 ± 22.3, 63 ± 19, 61 ± 11, and 52 ± 9.2, respectively.

Conclusions

This study confirms that LSG is safe and has very low rates of early and long-term complications when compared to other well-established procedures. Additionally, LSG that appears results in significant improvement of obesity-related comorbid conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. D’Hondt M, Pottel H, Devriendt D, Van Rooy F, Vansteenkiste F (2011) Laparoscopic sleeve gastrectomy as a single-stage procedure for the treatment of morbid obesity and the resulting quality of life, resolution of comorbidities, food tolerance, and 6-year weight loss. Surg Endosc 25:2498–2504

    Article  PubMed  Google Scholar 

  2. Strain GW, Saif T, Gagner M, Rossidis M, Dakin G, Pomp A (2011) Cross-sectional review of effects of laparoscopic sleeve gastrectomy at 1, 3, and 5 years. Surg Obes Relat Dis 7:714–719

    Article  PubMed  Google Scholar 

  3. Rawlins L, Rawlins MP, Brown CC, Schumacher DL (2013) Sleeve gastrectomy: 5-year outcomes of a single institution. Surg Obes Relat Dis 9:21–25

    Article  PubMed  Google Scholar 

  4. Rosenthal RJ, Panel ISGE (2012) International sleeve gastrectomy expert panel consensus statement: best practice guidelines based on experience of > 12,000 cases. Surg Obes Relat Dis 8:8–19

    Article  PubMed  Google Scholar 

  5. Iannelli A, Dainese R, Piche T, Facchiano E, Gugenheim J (2008) Laparoscopic sleeve gastrectomy for morbid obesity. World J Gastroenterol 14:821–827

    Article  PubMed  PubMed Central  Google Scholar 

  6. Roa PE, Kaider-Person O, Pinto D, Cho M, Szomstein S, Rosenthal RJ (2006) Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg 16:1323–1326

    Article  PubMed  Google Scholar 

  7. Ren CJ, Patterson E, Gagner M (2000) Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg 10:514–523

    Article  CAS  PubMed  Google Scholar 

  8. Regan JP, Inabnet W, Gagner M, Pomp A (2003) Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super-obese patient. Obes Surg 13:861–864

    Article  CAS  PubMed  Google Scholar 

  9. Himpens J, Daprie G, Cadiere GB (2006) A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg 16:1450–1456

    Article  PubMed  Google Scholar 

  10. Milone L, Strong V, Gagner M (2005) Laparoscopic sleeve gastrectomy is superior to intragastric balloon as a first-stage procedure for super-obese patients (BMI > 50 kg/m2). Obes Surg 15:612–617

    Article  PubMed  Google Scholar 

  11. Fridman A, Moon R, Cozacov Y, Ampudia C, Lo Menzo E, Szomstein S, Rosenthal RJ (2013) Procedure-related morbidity in bariatric surgery: a retrospective short- and mid-term follow-up of a single institution of the American College of Surgeons Bariatric Surgery Centers of Excellence. J Am Coll Surg 4:614–620

    Article  Google Scholar 

  12. Tucker ON, Szomstein S, Rosenthal RJ (2008) Indications for sleeve gastrectomy as a primary procedure for weight loss in the morbidly obese. J Gastrointest Surg 12:662–667

    Article  CAS  PubMed  Google Scholar 

  13. Oien DM, Buchwald H (2013) Metabolic/bariatric surgery worldwide 2011. Obes Surg 23:227–436

    Google Scholar 

  14. Victorzon M (2012) An update on sleeve gastrectomy. Minerva Chir 67:153–163

    CAS  PubMed  Google Scholar 

  15. Choi YY, Bae J, Hur KY, Choi D, Kim YJ (2012) Reinforcing the staple line during laparoscopic sleeve gastrectomy: does it have advantages? A meta-analysis. Obes Surg 22:1206–1213

    Article  PubMed  Google Scholar 

  16. Bellanger D, Greenway FL (2011) Laparoscopic sleeve gastrectomy, 529 cases without a leak: short-term results and technical considerations. Obes Surg 21:146–150

    Article  PubMed  Google Scholar 

  17. Fezzi M, Kolotkin R, Nedelcu M et al (2011) Improvement in quality of life after laparoscopic sleeve gastrectomy. Obes Surg 21:1161–1167

    Article  PubMed  Google Scholar 

  18. Eid GM, Brethauer S, Mattar SG, Titchner RL, Gourash W, Schauer PR (2012) Laparoscopic sleeve gastrectomy for super obese patients. Forty-eight percent excess weight loss after 6 to 8 years with 93% follow-up. Ann Surg 2:262–265

    Article  Google Scholar 

  19. Van Rutte P, Smulders JF, de Zoete JP, Nienhuijs SW (2014) Outcome on sleeve gastrectomy as primary bariatric procedure. Br J Surg 101:661–668

    Article  PubMed  Google Scholar 

  20. Marin-Perez P, Betancourt A, Lamota M, Lo Menzo E, Szomstein S, Rosenthal R (2014) Outcomes after laparoscopic conversion of failed adjustable gastric banding to sleeve gastrectomy or Roux-en-Y gastric bypass. BJS 101:254–260

    Article  CAS  Google Scholar 

  21. Sakran N, Goitein D, Raziel A et al (2013) Gastric leaks after sleeve gastrectomy: a multicenter experience with 2,834 patients. Surg Endosc 27:240–245

    Article  PubMed  Google Scholar 

  22. Lalor PF, Tucker ON, Szomstein S, Rosenthal RJ (2008) Complications after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis 1:33–38

    Article  Google Scholar 

  23. Aurora AR, Khaitan L, Saber AA (2012) Sleeve gastrectomy and the risk of leak: a systemic analysis of 4,888 patients. Surg Endosc 26:1509–1515

    Article  PubMed  Google Scholar 

  24. Spyropoulos C, Argentou MI, Petsas T, Thomopoulos K, Kehagias I, Kalfarentzos F (2012) Management of gastrointestinal leaks after surgery for clinically severe obesity. SOARD 8:609–615

    Google Scholar 

  25. Csendes A, Braghetto I, León P, Burgos AM (2010) Management of leaks after laparoscopic sleeve gastrectomy in patients with obesity. J Gastrointest Surg 14:1343–1348

    Article  PubMed  Google Scholar 

  26. Moon Han S, Kim WW, Oh JH (2005) Results of laparoscopic sleeve gastrectomy at 1 year in morbidly obese Korean patients. Obes Surg 15:1469–1475

    Article  PubMed  Google Scholar 

  27. Hamoui N, Anthone GJ, Kaufman HS, Crookes PF (2006) Sleeve gastrectomy in the high-risk patient. Obes Surg 16:1445–1449

    Article  PubMed  Google Scholar 

  28. Cottam D, Qureshi FG, Mattar SG et al (2006) Laparoscopic sleeve gastrectomy as an initial weight loss procedure for high risk patients with morbid obesity. Surg Endosc 20:859–863

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, Section of Minimally Invasive Surgery, The Bariatric and Metabolic Institute, Cleveland Clinic Florida, 2950 Cleveland Clinic Boulevard, Weston, FL, 33331, USA

    Emanuela Silva Alvarenga, Emanuele Lo Menzo, Samuel Szomstein & Raul J. Rosenthal

Authors
  1. Emanuela Silva Alvarenga
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emanuele Lo Menzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Samuel Szomstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Raul J. Rosenthal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raul J. Rosenthal.

Ethics declarations

Disclosures

Dr. Rosenthal is a speaker for Ethicon and has educational Grants from Ethicon, Covidien, and Karl Storz. Dr. Lo Menzo is a consultant for Baxter Healthcare Corporation. Dr. Szomstein is a consultant for Covidien and Ethicon. Dr. Alvarenga has no conflict of interest or financial ties to disclose.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alvarenga, E.S., Lo Menzo, E., Szomstein, S. et al. Safety and efficacy of 1020 consecutive laparoscopic sleeve gastrectomies performed as a primary treatment modality for morbid obesity. A single-center experience from the metabolic and bariatric surgical accreditation quality and improvement program. Surg Endosc 30, 2673–2678 (2016). https://doi.org/10.1007/s00464-015-4548-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-015-4548-4

Keywords

Search

Navigation